Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FDHT PET to visualize androgen receptor modulation by bicalutamide in metastatic breast cancer
2015-001634-17Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bicalutamide in breast cancer, sponsored by University Medical Center Groningen. Started Sep 2015; status: completed.
02
Drugs
bicalutamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2015-001634-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001634-17.